Global Pharmaceutical Excipients Market Report (2025–2036)
Market Overview
The global pharmaceutical excipients market was valued at USD xxxx million in 2025 and is projected to reach USD xxxx million by 2036, growing at a CAGR of xx%. Excipients are inactive substances used in drug formulations to aid stability, bioavailability, and patient compliance. Rising demand for advanced drug delivery systems, growth in generics, and innovation in biologics are fueling market expansion.
Impact of COVID-19
The pandemic disrupted supply chains in 2020 but accelerated demand for excipients due to increased pharmaceutical production, especially in vaccines and therapeutics. Post-pandemic, the market has seen heightened focus on excipients that enhance drug stability and support large-scale manufacturing.
Segmentation Analysis
By Type
· Binders
· Glidents
· Diluents
· Disintegrants
· Lubricants
· Coating Agents
· Preservatives
· Flavoring Agents
· Others
By Application
· Oral Formulations (tablets, capsules, syrups)
· Topical Formulations (ointments, creams, gels)
· Parenteral Formulations (injectables)
· Biopharmaceuticals & Advanced Drug Delivery
· Others
By Functionality
· Fillers & Diluents
· Stabilizers
· Controlled-release Agents
· Solubilizers
· Sweeteners & Flavoring Agents
Regional Analysis
· North America: Leading market due to advanced pharmaceutical industry, strong R&D investments, and presence of major players.
· Europe: Growth supported by regulatory frameworks, innovation in excipient technologies, and demand for generics.
· Asia-Pacific: Fastest-growing region, driven by expanding pharmaceutical manufacturing in India and China, rising healthcare demand, and government support.
· South America: Moderate growth, with Brazil leading in pharmaceutical production.
· Middle East & Africa: Emerging opportunities with increasing healthcare investments and demand for affordable medicines.
Key Players
· DowDuPont (FMC)
· ER-KANG
· JRS Pharma
· BASF SE
· Lubrizol Corporation
· Ashland Global Holdings
· Roquette Frères
· Shin-Etsu Chemical Co. Ltd.
· Evonik Industries AG
· Associated British Foods Plc
· Anhui Sunhere Pharmaceutical Excipients Co. Ltd.
· Chase Sun Pharmaceutical
· Shenzhou Yiqiao
· EHUA
· Colorcon Inc.
· Croda International Plc
· Kerry Group Plc
· Meggle Pharma
· Avantor Inc.
Porter’s Five Forces
· Threat of New Entrants: Low, due to high regulatory barriers and capital requirements.
· Bargaining Power of Suppliers: Moderate, with reliance on specialized raw materials.
· Bargaining Power of Buyers: High, as pharmaceutical companies demand cost-effective and high-quality excipients.
· Threat of Substitutes: Low, as excipients are essential in formulations.
· Industry Rivalry: High, with global players competing on innovation, quality, and pricing.
SWOT Analysis
Strengths: Essential role in drug formulation, wide application across dosage forms. Weaknesses: Regulatory complexity, high R&D costs. Opportunities: Growth in biologics, personalized medicine, and novel drug delivery systems. Threats: Counterfeit products, raw material price fluctuations, competition from alternative technologies.
Trend Analysis
· Rising demand for functional excipients that improve bioavailability.
· Increasing adoption of natural and plant-based excipients.
· Growth in controlled-release and targeted drug delivery systems.
· Expansion of biopharmaceutical excipients for advanced therapies.
Drivers & Challenges
Drivers:
· Rising prevalence of chronic diseases.
· Growth in generics and biosimilars.
· Increasing R&D in drug delivery technologies.
Challenges:
· Stringent regulatory requirements.
· High production and compliance costs.
· Limited awareness in developing regions.
Value Chain Analysis
· Raw Material Suppliers (chemicals, natural sources) → Excipients Manufacturers → Pharmaceutical Companies → Distributors/Retailers → End Patients
· Integration of advanced technologies and partnerships between excipient suppliers and pharma companies are reshaping the value chain.
Recommendations for Stakeholders
· Manufacturers: Invest in functional and biologics-compatible excipients.
· Pharmaceutical Companies: Collaborate with excipient suppliers for innovative drug delivery solutions.
· Investors: Focus on Asia-Pacific for high growth potential.
· Policy Makers: Streamline regulatory processes and encourage sustainable excipient production.
1. Market Overview of Pharmaceutical Excipients
1.1 Pharmaceutical Excipients Market Overview
1.1.1 Pharmaceutical Excipients Product Scope
1.1.2 Market Status and Outlook
1.2 Pharmaceutical Excipients Market Size by Regions:
1.3 Pharmaceutical Excipients Historic Market Size by Regions
1.4 Pharmaceutical Excipients Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Pharmaceutical Excipients Sales Market by Type
2.1 Global Pharmaceutical Excipients Historic Market Size by Type
2.2 Global Pharmaceutical Excipients Forecasted Market Size by Type
2.3 Binder
2.4 Glidents
2.5 Diluents
2.6 Disintegrants
2.7 Others
3. Covid-19 Impact Pharmaceutical Excipients Sales Market by Application
3.1 Global Pharmaceutical Excipients Historic Market Size by Application
3.2 Global Pharmaceutical Excipients Forecasted Market Size by Application
3.3 Oral Formulations
3.4 Topical Formulations
3.5 Parenteral Formulations
3.6 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Pharmaceutical Excipients Production Capacity Market Share by Manufacturers
4.2 Global Pharmaceutical Excipients Revenue Market Share by Manufacturers
4.3 Global Pharmaceutical Excipients Average Price by Manufacturers
5. Company Profiles and Key Figures in Pharmaceutical Excipients Business
5.1 DowDuPont (FMC)
5.1.1 DowDuPont (FMC) Company Profile
5.1.2 DowDuPont (FMC) Pharmaceutical Excipients Product Specification
5.1.3 DowDuPont (FMC) Pharmaceutical Excipients Production Capacity, Revenue, Price and Gross Margin
5.2 ER-KANG
5.2.1 ER-KANG Company Profile
5.2.2 ER-KANG Pharmaceutical Excipients Product Specification
5.2.3 ER-KANG Pharmaceutical Excipients Production Capacity, Revenue, Price and Gross Margin
5.3 JRS Pharma
5.3.1 JRS Pharma Company Profile
5.3.2 JRS Pharma Pharmaceutical Excipients Product Specification
5.3.3 JRS Pharma Pharmaceutical Excipients Production Capacity, Revenue, Price and Gross Margin
5.4 BASF
5.4.1 BASF Company Profile
5.4.2 BASF Pharmaceutical Excipients Product Specification
5.4.3 BASF Pharmaceutical Excipients Production Capacity, Revenue, Price and Gross Margin
5.5 Lubrizol
5.5.1 Lubrizol Company Profile
5.5.2 Lubrizol Pharmaceutical Excipients Product Specification
5.5.3 Lubrizol Pharmaceutical Excipients Production Capacity, Revenue, Price and Gross Margin
5.6 Ashland
5.6.1 Ashland Company Profile
5.6.2 Ashland Pharmaceutical Excipients Product Specification
5.6.3 Ashland Pharmaceutical Excipients Production Capacity, Revenue, Price and Gross Margin
5.7 Roquette
5.7.1 Roquette Company Profile
5.7.2 Roquette Pharmaceutical Excipients Product Specification
5.7.3 Roquette Pharmaceutical Excipients Production Capacity, Revenue, Price and Gross Margin
5.8 Shin-Etsu
5.8.1 Shin-Etsu Company Profile
5.8.2 Shin-Etsu Pharmaceutical Excipients Product Specification
5.8.3 Shin-Etsu Pharmaceutical Excipients Production Capacity, Revenue, Price and Gross Margin
5.9 Evonik
5.9.1 Evonik Company Profile
5.9.2 Evonik Pharmaceutical Excipients Product Specification
5.9.3 Evonik Pharmaceutical Excipients Production Capacity, Revenue, Price and Gross Margin
5.10 Associated British Foods
5.10.1 Associated British Foods Company Profile
5.10.2 Associated British Foods Pharmaceutical Excipients Product Specification
5.10.3 Associated British Foods Pharmaceutical Excipients Production Capacity, Revenue, Price and Gross Margin
5.11 Anhui Sunhere Pharmaceutical
5.11.1 Anhui Sunhere Pharmaceutical Company Profile
5.11.2 Anhui Sunhere Pharmaceutical Pharmaceutical Excipients Product Specification
5.11.3 Anhui Sunhere Pharmaceutical Pharmaceutical Excipients Production Capacity, Revenue, Price and Gross Margin
5.12 CHASE SUN
5.12.1 CHASE SUN Company Profile
5.12.2 CHASE SUN Pharmaceutical Excipients Product Specification
5.12.3 CHASE SUN Pharmaceutical Excipients Production Capacity, Revenue, Price and Gross Margin
5.13 Shenzhou Yiqiao
5.13.1 Shenzhou Yiqiao Company Profile
5.13.2 Shenzhou Yiqiao Pharmaceutical Excipients Product Specification
5.13.3 Shenzhou Yiqiao Pharmaceutical Excipients Production Capacity, Revenue, Price and Gross Margin
5.14 EHUA
5.14.1 EHUA Company Profile
5.14.2 EHUA Pharmaceutical Excipients Product Specification
5.14.3 EHUA Pharmaceutical Excipients Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Pharmaceutical Excipients Market Size
6.2 North America Pharmaceutical Excipients Key Players in North America
6.3 North America Pharmaceutical Excipients Market Size by Type
6.4 North America Pharmaceutical Excipients Market Size by Application
7. East Asia
7.1 East Asia Pharmaceutical Excipients Market Size
7.2 East Asia Pharmaceutical Excipients Key Players in North America
7.3 East Asia Pharmaceutical Excipients Market Size by Type
7.4 East Asia Pharmaceutical Excipients Market Size by Application
8. Europe
8.1 Europe Pharmaceutical Excipients Market Size
8.2 Europe Pharmaceutical Excipients Key Players in North America
8.3 Europe Pharmaceutical Excipients Market Size by Type
8.4 Europe Pharmaceutical Excipients Market Size by Application
9. South Asia
9.1 South Asia Pharmaceutical Excipients Market Size
9.2 South Asia Pharmaceutical Excipients Key Players in North America
9.3 South Asia Pharmaceutical Excipients Market Size by Type
9.4 South Asia Pharmaceutical Excipients Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Pharmaceutical Excipients Market Size
10.2 Southeast Asia Pharmaceutical Excipients Key Players in North America
10.3 Southeast Asia Pharmaceutical Excipients Market Size by Type
10.4 Southeast Asia Pharmaceutical Excipients Market Size by Application
11. Middle East
11.1 Middle East Pharmaceutical Excipients Market Size
11.2 Middle East Pharmaceutical Excipients Key Players in North America
11.3 Middle East Pharmaceutical Excipients Market Size by Type
11.4 Middle East Pharmaceutical Excipients Market Size by Application
12. Africa
12.1 Africa Pharmaceutical Excipients Market Size
12.2 Africa Pharmaceutical Excipients Key Players in North America
12.3 Africa Pharmaceutical Excipients Market Size by Type
12.4 Africa Pharmaceutical Excipients Market Size by Application
13. Oceania
13.1 Oceania Pharmaceutical Excipients Market Size
13.2 Oceania Pharmaceutical Excipients Key Players in North America
13.3 Oceania Pharmaceutical Excipients Market Size by Type
13.4 Oceania Pharmaceutical Excipients Market Size by Application
14. South America
14.1 South America Pharmaceutical Excipients Market Size
14.2 South America Pharmaceutical Excipients Key Players in North America
14.3 South America Pharmaceutical Excipients Market Size by Type
14.4 South America Pharmaceutical Excipients Market Size by Application
15. Rest of the World
15.1 Rest of the World Pharmaceutical Excipients Market Size
15.2 Rest of the World Pharmaceutical Excipients Key Players in North America
15.3 Rest of the World Pharmaceutical Excipients Market Size by Type
15.4 Rest of the World Pharmaceutical Excipients Market Size by Application
16 Pharmaceutical Excipients Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Segmentation Analysis
By Type
· Binders
· Glidents
· Diluents
· Disintegrants
· Lubricants
· Coating Agents
· Preservatives
· Flavoring Agents
· Others
By Application
· Oral Formulations (tablets, capsules, syrups)
· Topical Formulations (ointments, creams, gels)
· Parenteral Formulations (injectables)
· Biopharmaceuticals & Advanced Drug Delivery
· Others
By Functionality
· Fillers & Diluents
· Stabilizers
· Controlled-release Agents
· Solubilizers
· Sweeteners & Flavoring Agents
Regional Analysis
· North America: Leading market due to advanced pharmaceutical industry, strong R&D investments, and presence of major players.
· Europe: Growth supported by regulatory frameworks, innovation in excipient technologies, and demand for generics.
· Asia-Pacific: Fastest-growing region, driven by expanding pharmaceutical manufacturing in India and China, rising healthcare demand, and government support.
· South America: Moderate growth, with Brazil leading in pharmaceutical production.
· Middle East & Africa: Emerging opportunities with increasing healthcare investments and demand for affordable medicines.
Key Players
· DowDuPont (FMC)
· ER-KANG
· JRS Pharma
· BASF SE
· Lubrizol Corporation
· Ashland Global Holdings
· Roquette Frères
· Shin-Etsu Chemical Co. Ltd.
· Evonik Industries AG
· Associated British Foods Plc
· Anhui Sunhere Pharmaceutical Excipients Co. Ltd.
· Chase Sun Pharmaceutical
· Shenzhou Yiqiao
· EHUA
· Colorcon Inc.
· Croda International Plc
· Kerry Group Plc
· Meggle Pharma
· Avantor Inc.
